StreetInsider.com News Articles

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

Wed, 27 May 2026 16:05:00 -0400

BERKELEY, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 2:35pm ET in New York.

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

Wed, 27 May 2026 16:05:00 -0400

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

Wed, 27 May 2026 16:05:00 -0400

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

Wed, 27 May 2026 16:05:00 -0400

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference

Wed, 13 May 2026 16:05:00 -0400

BERKELEY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that Caribou’s management team will participate in a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026, at 12:30pm ET in New York, New York.

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference

Wed, 13 May 2026 16:05:00 -0400

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference

Wed, 13 May 2026 16:05:00 -0400

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference

Wed, 13 May 2026 16:05:00 -0400

For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting